Skip to main content
All lobbying filings

Kelley Drye & Warren LLP

Kelley Drye & Warren LLP filed a Q1 report for Laboratory Corporation of America Holdings on April 20, 2026, reporting $110,000 in lobbying income.

Lobbying for Laboratory Corporation of America Holdings · Clinical laboratory

As filed: KELLEY DRYE & WARREN LLP for LABORATORY CORPORATION OF AMERICA HOLDINGS.

All filings by Kelley Drye & Warren LLP · Everything Laboratory Corporation of America Holdings has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$110,000
What the client paid this registrant for the period.
Client based in
North Carolina

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Healthcare issues relating to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, and Section 6226 of H.R. 7148, the Consolidated Appropriations Act, 2026, Pub. L. 119-75, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.

 Bills named in this filing 3

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem